PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

64 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
21.
Brunner, F.J.* et al.: Application of non-HDL cholesterol for population-based cardiovascular risk stratification: Results from the Multinational Cardiovascular Risk Consortium. Lancet 394, 2173-2183 (2019)
22.
Matthews, D.R.* et al.: Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): A 5-year, multicentre, randomised, double-blind trial. Lancet 394, 1519-1529 (2019)
23.
Lorkowski, S.* ; Richter, M.* ; Linseisen, J. & Watzl, B.*: Associations of fats and carbohydrates with cardiovascular disease and mortality—PURE and simple? Lancet 391, 1678-1679 (2018)
24.
Stumvoll, M.* & Tschöp, M.H.: Twice the benefits with twincretins? Lancet 392, 2142-2144 (2018)
25.
Wood, A.M.* et al.: Risk thresholds for alcohol consumption: Combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet 391, 1513-1523 (2018)
26.
EUMODIC Consortium (Döring, A. ; Meisinger, C. ; Müller-Nurasyid, M. ; Peters, A. ; Stieber, J. ; Stöckl, D.): Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet 389, 37-55 (2017)
27.
Ezzati, M.* et al.: Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet 390, 2627-2642 (2017)
28.
NCD Risk Factors Collaboration et al.: Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet 387, 1377-1396 (2016)
29.
NCD Risk Factors Collaboration (Müller-Nurasyid, M. ; Peters, A. ; Stöckl, D. ; Ezzati, M.*): Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 387, 1513-1530 (2016)
30.
Miras, A.* et al.: Ovarian hyperstimulation from ectopic hypersecretion of follicle stimulating hormone. Lancet 385, 392 (2015)
31.
Swerdlow, D.I.* et al.: HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: Evidence from genetic analysis and randomised trials. Lancet 385, 351-361 (2015)
32.
Dick, K.J.* et al.: DNA methylation and body-mass index: A genome-wide analysis. Lancet 383, 1990-1998 (2014)
33.
Wormser, D.* et al.: Metabolic mediators of body-mass index and cardiovascular risk. Lancet 383, 2042-2043 (2014)
34.
Beelen, R.* et al.: Effects of long-term exposure to air pollution on natural-cause mortality: An analysis of 22 European cohorts within the multicentre ESCAPE project. Lancet 383, 785-795 (2013)
35.
Moran, A.* et al.: Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicentre, randomised, double-blind, placebo-controlled trials. Lancet 381, 1905-1915 (2013)
36.
IL6R Genetics Consortium & Emerging Risk Factors Collaboration (Döring, A. ; Meisinger, C.): Interleukin-6 receptor pathways in coronary heart disease: A collaborative meta-analysis of 82 studies. Lancet 379, 1205-1213 (2012)
37.
Fernandez, I.E. & Eickelberg, O.: New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis. Lancet 380, 680-688 (2012)
38.
Rauch, A.* et al.: Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: An exome sequencing study. Lancet 380, 1674-1682 (2012)
39.
Emerging Risk Factors Collaboration (Döring, A. ; Meisinger, C.): Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: Collaborative analysis of 58 prospective studies. Lancet 377, 1085-1095 (2011)
40.
Gutermuth, J. et al.: Papular-purpuric gloves and socks syndrome. Lancet 378, 198 (2011)